RicercaInizia una nuova ricerca
NOTA: è possibile cercare una corrispondenza esatta usando i doppi apici, ad es: "evoluzione della specie". Qualora si cerchi un identificativo, è consigliabile cercarlo in due modi differenti: tra apici con caratteri speciali es: "978-94-6366-274" oppure senza caratteri speciali solo come sequenza numerica: es 978946366274.
Spleen sizing by ultrasound scan and risk of pneumococcal infection in patients with chronic GvHD.
1999-01-01 Picardi, M; Selleri, Carmine; Califano, C; Rotoli, B.
Stem cell transplantation (SCT) complicated by hepatitis B (HBV) and hepatitis C (HCV) virus infection: A multicenter study from gitmo (SCT Italian group).
1999-01-01 Locasciulli, A; Nava, S; Meloni, G; Alessandrino, P; Cesana, C; De Rosa, G; Selleri, Carmine; Bergonzi, C; Irrera, G; Raimondi, R; Cesaro, S; Arcese, Wg; Bacigalupo, A; Biondi, A.
Subcutaneous alemtuzumab as treatment option for patients with severe aplastic anemia or lineage-restricted aplasia.
2006-01-01 Risitano, Am; Selleri, Carmine; Camera, A; Gallotta, G; Perna, F; Copeta, G; Rotoli, B.
Subcutaneous Alemtuzumab Is a safe and effective treatment for global or single lineage immune-mediated marrow failures: a survey from the EBMT-WPSAA.
2008-01-01 Risitano, Am; Seneca, E; Marando, L; Serio, B; Selleri, Carmine; Scalia, G; Del Vecchio, L; Iori, A; Kulagin, A; Maury, S; Halter, J; Gupta, V; Bacigalupo, A; Sociè, G; Tichelli, A; Marh, J; Schrezenmeier, H; Passweg, Jr; Rotoli, B.
Subcutaneous alemtuzumab is safe and effective for treatment of global or single-lineage immune-mediated marrow failure: a pilot study from the working party aplastic anaemia (WPSAA)
2008-01-01 Risitano, A; Marando, L; Selleri, Carmine; Serio, B; Seneca, E; Camera, A; L., Catalano; G., Scalia; L., Del Vecchio; A., Iori; S., Maury; A., Bacigalupo; G., Sociè; A., Tichelli; J., Marsh
Subcutaneous low-dose IL-2 for remission maintenance in elderly acute myeloid leukemia patients.
1996-01-01 R., Notaro; Selleri, Carmine; G., Caparrotti; M., Picardi; di Grazia, C; D., Pagnini; N., Cantore; A., Andriani; Carella, M; L., Catalano; L., Del Vecchio; R., Di Girolamo; E., Volpe; M., Carotenuto; B., Rotoli
Subeutaneous alemtuzumab is safe and effective for treatment of global or single-lineage immune-mediated marrow failure: A pilot study.
2007-01-01 Risitano, Am; Selleri, Carmine; Serio, B; Marando, L; Camera, A; Catalano, L.
Successful use of CD34+ enriched donor lymphocyte infusion in a case of hodgkin’s disease relapsing after allogeneic BMT.
1999-01-01 G., De Rosa; L., Pezzullo; A., Lucania; Selleri, Carmine; N., Scarpato; B., Rotoli
Sustained long-term quantitative defect in the stem cell compartment despite hematologic recovery in patients with aplastic anemia.
1998-01-01 Maciejewski, Jp; Kim, S; Sloand, E; Selleri, Carmine; Rosenfeld, Sj; Young, N. S.
The cleaved form of soluble urokinase-receptor stimulates migration and mobilization of mouse CD34(+) cells in vitro and in vivo
2007-01-01 Selleri, Carmine; Montuori, N; Ricci, F; Cerciello, G; Cuccurullo, R; Rotoli, B; Rossi, G; Ragno, Pia
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Spleen sizing by ultrasound scan and risk of pneumococcal infection in patients with chronic GvHD. | 1-gen-1999 | Picardi, M; Selleri, Carmine; Califano, C; Rotoli, B. | |
| Stem cell transplantation (SCT) complicated by hepatitis B (HBV) and hepatitis C (HCV) virus infection: A multicenter study from gitmo (SCT Italian group). | 1-gen-1999 | Locasciulli, A; Nava, S; Meloni, G; Alessandrino, P; Cesana, C; De Rosa, G; Selleri, Carmine; Bergonzi, C; Irrera, G; Raimondi, R; Cesaro, S; Arcese, Wg; Bacigalupo, A; Biondi, A. | |
| Subcutaneous alemtuzumab as treatment option for patients with severe aplastic anemia or lineage-restricted aplasia. | 1-gen-2006 | Risitano, Am; Selleri, Carmine; Camera, A; Gallotta, G; Perna, F; Copeta, G; Rotoli, B. | |
| Subcutaneous Alemtuzumab Is a safe and effective treatment for global or single lineage immune-mediated marrow failures: a survey from the EBMT-WPSAA. | 1-gen-2008 | Risitano, Am; Seneca, E; Marando, L; Serio, B; Selleri, Carmine; Scalia, G; Del Vecchio, L; Iori, A; Kulagin, A; Maury, S; Halter, J; Gupta, V; Bacigalupo, A; Sociè, G; Tichelli, A; Marh, J; Schrezenmeier, H; Passweg, Jr; Rotoli, B. | |
| Subcutaneous alemtuzumab is safe and effective for treatment of global or single-lineage immune-mediated marrow failure: a pilot study from the working party aplastic anaemia (WPSAA) | 1-gen-2008 | Risitano, A; Marando, L; Selleri, Carmine; Serio, B; Seneca, E; Camera, A; L., Catalano; G., Scalia; L., Del Vecchio; A., Iori; S., Maury; A., Bacigalupo; G., Sociè; A., Tichelli; J., Marsh | |
| Subcutaneous low-dose IL-2 for remission maintenance in elderly acute myeloid leukemia patients. | 1-gen-1996 | R., Notaro; Selleri, Carmine; G., Caparrotti; M., Picardi; di Grazia, C; D., Pagnini; N., Cantore; A., Andriani; Carella, M; L., Catalano; L., Del Vecchio; R., Di Girolamo; E., Volpe; M., Carotenuto; B., Rotoli | |
| Subeutaneous alemtuzumab is safe and effective for treatment of global or single-lineage immune-mediated marrow failure: A pilot study. | 1-gen-2007 | Risitano, Am; Selleri, Carmine; Serio, B; Marando, L; Camera, A; Catalano, L. | |
| Successful use of CD34+ enriched donor lymphocyte infusion in a case of hodgkin’s disease relapsing after allogeneic BMT. | 1-gen-1999 | G., De Rosa; L., Pezzullo; A., Lucania; Selleri, Carmine; N., Scarpato; B., Rotoli | |
| Sustained long-term quantitative defect in the stem cell compartment despite hematologic recovery in patients with aplastic anemia. | 1-gen-1998 | Maciejewski, Jp; Kim, S; Sloand, E; Selleri, Carmine; Rosenfeld, Sj; Young, N. S. | |
| The cleaved form of soluble urokinase-receptor stimulates migration and mobilization of mouse CD34(+) cells in vitro and in vivo | 1-gen-2007 | Selleri, Carmine; Montuori, N; Ricci, F; Cerciello, G; Cuccurullo, R; Rotoli, B; Rossi, G; Ragno, Pia |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Opzioni
Scopri
Tipologia
- 1 Contributo su Rivista 127
- 1 Contributo su Rivista::1.5 Abst... 127
Data di pubblicazione
- 2020 - 2022 9
- 2010 - 2019 40
- 2000 - 2009 31
- 1991 - 1999 47
Rivista
- HAEMATOLOGICA 48
- BLOOD 34
- BONE MARROW TRANSPLANTATION 23
- HAEMATOLOGICA 11
- TRANSLATIONAL MEDICINE @ UNISA 3
- BONE MARROW TRANSPLANTATION 1
- CYTOMETRY. PART A 1
- EUROPEAN JOURNAL OF NUCLEAR MEDIC... 1
- JOURNAL OF BONE AND MINERAL RESEARCH 1
- JOURNAL OF ENDOCRINOLOGICAL INVES... 1
Keyword
- autologous bone graft 2
- HEMATOPOIETIC STEM CELL MOBILIZATION 1
- LAMININ RECEPTOR 1
- laminin receptor 1
- vitronectin 1
Lingua
- eng 124
Accesso al fulltext
- no fulltext 127